Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Empower Clinics Inc. operates a network of healthcare facilities in North America, focusing on providing integrated medical services, including telehealth and laboratory testing. Its competitive position is bolstered by its emphasis on patient-centered care and a diverse service offering that includes cannabis-related health services.
Empower Clinics generates revenue through a combination of telehealth consultations, laboratory testing services, and cannabis-related health services. The company benefits from pricing power due to its unique service offerings and the growing acceptance of telehealth, which has seen increased demand post-pandemic.
Regulatory changes impacting telehealth reimbursement policies
Expansion of healthcare services in new geographic markets
Patient volume growth in telehealth and lab services
Strategic partnerships with healthcare providers
Regulatory changes affecting telehealth and cannabis services
Technological disruption in healthcare delivery
Emerging telehealth competitors with advanced technology
Price competition from larger healthcare providers
Negative operating cash flow impacting liquidity
High operational leverage leading to potential financial strain
moderate - The healthcare sector is somewhat insulated from economic downturns, but discretionary spending on certain services may decline during recessions.
Higher interest rates could increase borrowing costs for expansion and impact consumer spending on healthcare services, potentially affecting demand.
minimal - The company has a negative debt/equity ratio, indicating it is not heavily reliant on credit.
growth - Investors seeking exposure to the expanding telehealth and integrated healthcare market.
high - The stock has shown significant price volatility, evidenced by a 300% return over the last three months followed by a 68% decline over six months.
